Cargando…

IGFBP2 is a potential biomarker in acute kidney injury (AKI) and resveratrol-loaded nanoparticles prevent AKI

This study aims to determine whether insulin-like growth factor binding protein2 (IGFBP2) is a useful biomarker for early diagnosis of acute kidney injury (AKI), evaluate the therapeutic effects of resveratrol-loaded nanoparticles (Res-NPs), and investigate the possible underlying mechanisms in a ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hai-Lun, Yan, Zhuan, Ke, Zun-Ping, Tian, Xiao-Feng, Zhong, Li-Li, Lin, Yong-Tao, Xu, Yong, Zheng, Dong-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290963/ https://www.ncbi.nlm.nih.gov/pubmed/30564296 http://dx.doi.org/10.18632/oncotarget.25663

Ejemplares similares

Subclinical AKI is still AKI
por: Ronco, Claudio, et al.
Publicado: (2012)

The rate of acute kidney injury (AKI) alert detection by the attending physicians was associated with the prognosis of patients with AKI
por: Shi, Yu, et al.
Publicado: (2022)

First Post-Operative Urinary Kidney Injury Biomarkers and Association with the Duration of AKI in the TRIBE-AKI Cohort
por: Coca, Steven G., et al.
Publicado: (2016)

Acute Kidney Injury (AKI)
por: Malhotra, Ajai
Publicado: (2017)

Incidence and In‐Hospital Mortality of Acute Kidney Injury (AKI) and Dialysis‐Requiring AKI (AKI‐D) After Cardiac Catheterization in the National Inpatient Sample
por: Brown, Jeremiah R., et al.
Publicado: (2016)

Comparison between acute kidney injury (AKI) and non‐AKI patients secondary to severe hypothyroidism
por: Han, Bing, et al.
Publicado: (2018)

Deletion of Antigen-Presenting Cells in Lipopolysaccharide-Induced Acute Kidney Injury (AKI) Affects the Exacerbation and Repair in AKI
por: Li, Jinhai, et al.
Publicado: (2022)

Cardiac Surgery Associated AKI Prevention Strategies and Medical Treatment for CSA-AKI
por: Ostermann, Marlies, et al.
Publicado: (2021)

Clinical Advances in Kidney Failure: AKI
por: Awad, Alaa S., et al.
Publicado: (2023)

Urine TIMP2 × IGFBP7 increases 24 hours before severe AKI
por: Ostermann, M, et al.
Publicado: (2014)

Latent AKI is… still AKI: the quantification of the burden of renal dysfunction
por: Ricci, Zaccaria, et al.
Publicado: (2016)

Epidemiology of AKI: Utilizing Large Databases to Determine the Burden of AKI
por: Sawhney, Simon, et al.
Publicado: (2017)

Advances in the study of subclinical AKI biomarkers
por: Zou, Chenchen, et al.
Publicado: (2022)

Demographic data for urinary Acute Kidney Injury (AKI) marker [IGFBP7]·[TIMP2] reference range determinations
por: Chindarkar, Nandkishor S., et al.
Publicado: (2015)

AKI and Transaminitis in a Kidney Transplant Patient
por: Lacave, Florian, et al.
Publicado: (2023)

The Utility of Novel Kidney Injury Biomarkers in Early Detection of CSA-AKI
por: Udzik, Jakub, et al.
Publicado: (2022)

Cardiopulmonary Bypass and AKI: AKI Is Bad, So Let's Get Beyond the Diagnosis
por: Krawczeski, Catherine D.
Publicado: (2019)

Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section
por: Ostermann, M., et al.
Publicado: (2019)

Urinary TIMP-2 and IGFBP7 elevate early in critically ill postoperative patients that develop AKI
por: Honore, P, et al.
Publicado: (2015)

Section 3: Prevention and Treatment of AKI
Publicado: (2012)

DPP4 inhibition prevents AKI
por: Reichetzeder, Christoph, et al.
Publicado: (2017)

The potential roles of galectin-3 in AKI and CKD
por: Wang, Fengyun, et al.
Publicado: (2023)

Kidney Microcirculation as a Target for Innovative Therapies in AKI
por: Ergin, Bülent, et al.
Publicado: (2021)

Lung Nodule and AKI in a Kidney Transplant Patient
por: Davis, Alyssa L., et al.
Publicado: (2023)

Are There Modifiable Risk Factors to Improve AKI?
por: Nie, Sasa, et al.
Publicado: (2017)

2416: A machine learning pipeline to predict acute kidney injury (AKI) in patients without AKI in their most recent hospitalization
por: Weisenthal, Samuel, et al.
Publicado: (2018)

Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers
por: Lentini, Paolo, et al.
Publicado: (2012)

Investigation of AKI with Early Biomarkers After Cardiac Surgery
por: Mutlu, Hüseyin, et al.
Publicado: (2020)

Molecular Mechanisms and Biomarkers Associated with Chemotherapy-Induced AKI
por: De Chiara, Letizia, et al.
Publicado: (2022)

Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial
por: Meersch, Melanie, et al.
Publicado: (2017)

Atradimų baimės didelės akys
Publicado: (2008)

Section 2: AKI Definition
Publicado: (2012)

NODding off AKI with Progranulin?
por: Tadagavadi, Raghu K., et al.
Publicado: (2015)

Global Perspectives in AKI: Argentina
por: De Arteaga, Javier, et al.
Publicado: (2023)

Global Perspectives in AKI: Peru
por: Herrera-Añazco, Percy, et al.
Publicado: (2023)

Epidemiology and outcomes of post-AKI proteinuria
por: Su, Licong, et al.
Publicado: (2023)

Fluid accumulation increases the risk of AKI progression and death in critically ill patients with early AKI
por: Raimundo, MR, et al.
Publicado: (2014)

The incidence and outcome of AKI in patients with sepsis in the emergency department applying different definitions of AKI and sepsis
por: Cobussen, Maarten, et al.
Publicado: (2022)

Development of a Risk Score for AKI onset in COVID-19 Patients: COV-AKI Score
por: Palomba, Henrique, et al.
Publicado: (2023)

The effects of timing onset and progression of AKI on the clinical outcomes in AKI patients with sepsis: a prospective multicenter cohort study
por: Wang, Meiping, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j0361tl1f86dm89tk3aceqa4sl